欧州連合（ＥＵ）の医薬品規制当局に続きWHOがこっそり目立たないようにDeath汁追加接種の方針転換

 

2022年1月12日水曜日

EU当局からの警告　頻繁なDeath汁接種は免疫システムに悪影響

https://tokumei10.blogspot.com/2022/01/eu.html

ブースター接種の繰り返し、免疫系に悪影響の恐れ－ＥＵ当局が警告

1/12(水) 4:45配信

（ブルームバーグ）： 欧州連合（ＥＵ）の医薬品規制当局は11日、新型コロナウイルスワクチンのブースター（追加免疫）接種を頻繁に行うと免疫系に悪影響を及ぼす恐れがあると警告した。

https://news.yahoo.co.jp/articles/e88dd2aead95c704a640eb3eab29616e34698967

 

Interim Statement on COVID-19 vaccines in the context of the circulation of the Omicron SARS-CoV-2 Variant from the WHO Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC)

11 January 2022

Statement

Reading time: 5 min (1345 words)With available COVID-19 vaccines, the current focus remains on reducing severe disease and death, as well as protecting health systems. Vaccines that have received WHO Emergency Use Listing, across several vaccine platforms, provide a high level of protection against severe disease and death caused by VOCs. For the Omicron variant, the mutational profile and preliminary data indicate that vaccine effectiveness will be reduced against symptomatic disease caused by the Omicron variant, but protection against severe disease is more likely to be preserved. However, more data on vaccine effectiveness, particularly against hospitalization, severe disease, and death are needed, including for each vaccine platform and for various vaccine dosing and product regimens.

In alignment with SAGE and its Working Group on COVID-19 Vaccines, the TAG-CO-VAC therefore supports urgent and broad access to current COVID-19 vaccines for priority populations worldwide to provide protection against severe disease and death globally and, in the longer term, to mitigate the emergence and impact of new VOCs by reducing the burden of infection. In practical terms, while some countries may recommend booster doses of vaccine, the immediate priority for the world is accelerating access to the primary vaccination, particularly for groups at greater risk of developing severe disease.[3]

With near- and medium-term supply of the available vaccines, the need for equity in access to vaccines across countries to achieve global public health goals, programmatic considerations including vaccine demand, and evolution of the virus, a vaccination strategy based on repeated booster doses of the original vaccine composition is unlikely to be appropriate or sustainable. 

 https://www.who.int/news/item/11-01-2022-interim-statement-on-covid-19-vaccines-in-the-context-of-the-circulation-of-the-omicron-sars-cov-2-variant-from-the-who-technical-advisory-group-on-covid-19-vaccine-composition

2022年1月11日火曜日

接種後数か月でVEがマイナスになるワクチンが長期的に身体に悪くないわけがない件

https://tokumei10.blogspot.com/2022/01/ve_11.html

2022年1月12日水曜日

Death汁大好きっ子へ　Pfizer CEO Albert Bourla: "Two doses of the vaccine offers very limited protection if any."

https://tokumei10.blogspot.com/2022/01/deathpfizer-ceo-albert-bourla-two-doses.html

、、、（爆ｗｗｗｗｗｗｗｗｗｗ